Clinical Trials Browser

Phase 1/2 × Waldenstrom Macroglobulinemia × oblimersen × Clear all

NCT00062244 2013-06-04

Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia

Phase 1/2 Completed

Waldenstrom Macroglobulinemia